Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Intermittent and short daily hemodialysis increase HGF plasma levels and diminish HCV viral load

View through CrossRef
Decrease of HCV viral load and HGF plasma levels increase have been related to HD sessions. Beneficial effects of HGF stimulation in HD on the outcome of HCV liver disease have been described. Aim was to analyze potential differences between intermittent (3 × week) and short daily (6 × week) HD, examining differences between HCV+ and – pts. We studied 41 pts from 2 HD centres, 26 on intermittent HD (6 on line HF), 8 HCV+, and 15 on short‐daily HD with 4 HCV+ 40 pts used synthetic HD membranes (low‐flux and high‐flux). Among HCV + we determined viral load by Amplicor (Roche) pre‐ and post‐ HD. All pts were studied for HGF levels (ELISA) baseline, 15 min, end, and at start of the following session viral load is significantly higher preHD and decreases over session. High‐flux membranes were more efficient in reducing viremia (67% vs 45%), which level was higher pre‐ and post‐HD principally in patients using low‐flux membranes. Viremia in DHD is lower than in intermittent (470067.3 ± 663974.5 vs 1015695.5 ± 1202679.0). HCV+ HCV− p HGF baseline 3261.3 ± 1904.5 2186.5 ± 815.7 0.01 HGF 15 min 8000.0 ± 0.0 7774.0 ± 1129.8 ns HGF end 6142.5 ± 2262.3 4443.7 ± 2515.7 0.03 HGF start 3391.0 ± 1680.6 2311.7 ± 633.6 0.007 HGF at baseline, at the end of the session, and starting the following one was significantly higher in HCV + patients. Maximum increase appears always at 15 min. HGF levels were significantly higher in daily HD than intermittent. Of the 14 patients who showed HGF after session higher than 8000, 8 were HCV+(3 in DHD, 5 high flux), 6 were HCV−(5 DHD and 3 high flux), 14 pts finished HD session with HGF>8000, 8HCV+(3 DHD, 5 high flux) and 6HCV−(5 DHD, 4 high‐flux). HGF stimulation appears in daily and intermittent HD, with higher level in the latter; HCV+ showed higher HGF vs negative, independently from the HD frequency; HCV viral load diminishes in all HD sessions, more in those with high‐flux membranes. Short‐daily HD with high‐flux synthetic membranes seems the best option for HCV+ patients, and when performed in home precludes nosocomial transmission.
Title: Intermittent and short daily hemodialysis increase HGF plasma levels and diminish HCV viral load
Description:
Decrease of HCV viral load and HGF plasma levels increase have been related to HD sessions.
Beneficial effects of HGF stimulation in HD on the outcome of HCV liver disease have been described.
Aim was to analyze potential differences between intermittent (3 × week) and short daily (6 × week) HD, examining differences between HCV+ and – pts.
We studied 41 pts from 2 HD centres, 26 on intermittent HD (6 on line HF), 8 HCV+, and 15 on short‐daily HD with 4 HCV+ 40 pts used synthetic HD membranes (low‐flux and high‐flux).
Among HCV + we determined viral load by Amplicor (Roche) pre‐ and post‐ HD.
All pts were studied for HGF levels (ELISA) baseline, 15 min, end, and at start of the following session viral load is significantly higher preHD and decreases over session.
High‐flux membranes were more efficient in reducing viremia (67% vs 45%), which level was higher pre‐ and post‐HD principally in patients using low‐flux membranes.
Viremia in DHD is lower than in intermittent (470067.
3 ± 663974.
5 vs 1015695.
5 ± 1202679.
0).
HCV+ HCV− p HGF baseline 3261.
3 ± 1904.
5 2186.
5 ± 815.
7 0.
01 HGF 15 min 8000.
0 ± 0.
0 7774.
0 ± 1129.
8 ns HGF end 6142.
5 ± 2262.
3 4443.
7 ± 2515.
7 0.
03 HGF start 3391.
0 ± 1680.
6 2311.
7 ± 633.
6 0.
007 HGF at baseline, at the end of the session, and starting the following one was significantly higher in HCV + patients.
Maximum increase appears always at 15 min.
HGF levels were significantly higher in daily HD than intermittent.
Of the 14 patients who showed HGF after session higher than 8000, 8 were HCV+(3 in DHD, 5 high flux), 6 were HCV−(5 DHD and 3 high flux), 14 pts finished HD session with HGF>8000, 8HCV+(3 DHD, 5 high flux) and 6HCV−(5 DHD, 4 high‐flux).
HGF stimulation appears in daily and intermittent HD, with higher level in the latter; HCV+ showed higher HGF vs negative, independently from the HD frequency; HCV viral load diminishes in all HD sessions, more in those with high‐flux membranes.
Short‐daily HD with high‐flux synthetic membranes seems the best option for HCV+ patients, and when performed in home precludes nosocomial transmission.

Related Results

T cell responses from blood donors infected with different HCV genotypes against HCV 1a proteins
T cell responses from blood donors infected with different HCV genotypes against HCV 1a proteins
Hepatitis C virus (HCV) infection, which can cause chronic liver diseases, cirrhosis and hepatocellular carcinoma, is still a major public health problem worldwide. Upon comparing ...
Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels
Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels
AbstractHemodialysis induces production of the hepatocyte growth factor (HGF) and decrease of serum hepatitis C virus (HCV) RNA in patients with HCV infection, but it is not known ...
Abstract 1627: Fibroblast HGF elicits c-MET-mediated signaling and migration in ovarian cancer cells.
Abstract 1627: Fibroblast HGF elicits c-MET-mediated signaling and migration in ovarian cancer cells.
Abstract Background: Epithelial ovarian cancer (EOC) has the highest mortality rate of all gynecologic malignancies diagnosed in the U.S. due to its rapid progressio...
Abstract 1583: SRI31215, a novel inhibitor of oncogenic HGF/MET signaling
Abstract 1583: SRI31215, a novel inhibitor of oncogenic HGF/MET signaling
Abstract Constitutive activation of MET signaling, frequently observed in cancer, triggers signaling by AKT, ERK 1/2 and STAT3, and promotes survival, proliferation,...
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis
Hepatocyte growth factor (HGF) is the most powerful hepatotrophic factor identified so far. However, the ability of HGF to promote tumor cell “scattering” and invasion raises some ...
HCV Co-Infection and Its Genotypic Distribution in HIV-Infected Patients in Nepalese Population
HCV Co-Infection and Its Genotypic Distribution in HIV-Infected Patients in Nepalese Population
Hepatitis C Virus (HCV) co-infection and its genotypic distribution in people living with Human Immunodeficiency Virus (HIV) show global inconsistency. Therefore, the present study...

Back to Top